Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience.

ABSTRACT:

Objectives

Access and appropriateness of therapeutics for COVID-19 vary because of access or regulatory barriers, the severity of the disease, and for some therapies, the stage of the pandemic and circulating variants. Remdesivir has shown benefits in clinical recovery and is the treatment of choice for selected patients, both hospitalized and nonhospitalized, in main international guidelines. The use of remdesivir in alternatives to conventional hospitalization such as hospital at home (HaH) units remains incompletely explored. In this study, we aim to describe the real-life experience of outpatient remdesivir infusion for COVID-19 in a HaH unit.

Methods

We selected all the consecutive patients receiving remdesivir from a prospective cohort of 507 COVID-19 patients admitted

SUBMITTER: Pereta I 

PROVIDER: S-EPMC9744477 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature